Sean Qiu, CFA, joined BeiGene in December 2021 as Executive Director, Product Strategy & Valuation. Prior to joining BeiGene, Sean was Senior Director of Corporate Strategy at Takeda Pharmaceuticals. He previously held various roles at Shire plc, Baxalta, and Baxter in corporate development and commercial strategy functions. Prior to entering the biopharma industry, Sean worked at EY’s Transaction Advisory Services focusing on M&A-related financial consulting services. Sean received his bachelor’s degree from Peking University and his master’s degrees from the University of Illinois at Urbana-Champaign. He is a Chartered Financial Analyst (CFA).